Murten, Switzerland

Max Maurer

This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Max Maurer: Innovator in Chemical Compounds

Introduction

Max Maurer is a notable inventor based in Murten, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of innovative chemical compounds. His work has led to the creation of a unique patent that showcases his expertise and creativity.

Latest Patents

Max Maurer holds a patent for N-3-(5-trifluoromethylpyridyl-2-oxy)phenyl-N'-benzoylureas. This invention relates to the use of specific chemical compounds that have potential applications in various industries. The formula of the compound includes R.sub.1, which can be hydrogen, C.sub.1 -C.sub.2 alkoxy, C.sub.1 -C.sub.2 alkylthio, C.sub.1 -C.sub.2 alkyl, or halogen. This patent highlights Maurer's innovative approach to chemical research and development.

Career Highlights

Throughout his career, Max Maurer has been associated with Ciba-Geigy Corporation, a prominent player in the chemical and pharmaceutical industry. His work at the company has allowed him to collaborate with other talented professionals and contribute to groundbreaking research.

Collaborations

Max Maurer has worked alongside esteemed colleagues such as Thomas Friedel and Walter Hausermann. These collaborations have enriched his research and have played a crucial role in the advancement of his inventions.

Conclusion

Max Maurer is a distinguished inventor whose work in chemical compounds has led to valuable patents and collaborations. His contributions continue to impact the field of chemistry and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…